Markets
markets
Luke Kawa

US chip designers surge as Commerce Department reverses restrictions on business in China

A couple of US semiconductor-adjacent companies are jumping on Thursday amid thawing on a contentious front in the US-China trade war: advanced technology.

Cadence Design Systems and Synopsys are surging after the Commerce Department told them they no longer need to secure licenses to do business in China.

These two electronic design automation (EDA) firms help chipmakers make chips. Not too many companies specialize in this, so it’s a fairly narrow choke point in the semiconductor supply chain to begin with.

These stocks got slammed in late May after the Financial Times reported that the president had ordered EDA companies to stop selling to Chinese groups.

In separate statements, Synopsys said that it’s “working to restore access to the recently restricted products in China,” while Cadence said it’s “in the process of restoring access to EDA Software and Technology for its affected customers.”

More Markets

See all Markets
markets

IREN drops on convertible debt offering

Shares of crypto miner and AI compute provider IREN dropped after the Australia-based, US-listed company said late Tuesday that it would sell $875 million in convertible senior debt.

The announcement came late in the trading day and caused a sell-off in the aftermarket session that continued into Wednesday trading.

The offering makes sense; the company can probably get some fairly cheap capital after its shares doubled over the last month.

But it exposes shareholders to some dilution risk if buyers of the hybrid securities do convert them into equity, which explains the market reaction.

The offering makes sense; the company can probably get some fairly cheap capital after its shares doubled over the last month.

But it exposes shareholders to some dilution risk if buyers of the hybrid securities do convert them into equity, which explains the market reaction.

markets

Tempus AI shares surge to all-time high

Shares of Tempus AI jumped over 7% Wednesday to reach an all-time high of $99.90. Shares of the AI medical diagnostics company are up over 191% for the year so far.

The company has recently announced a flurry of FDA clearances for its technologies. Most recently, on September 22, Tempus AI was granted FDA clearance for its Tempus xR IVD device, which is used to tailor cancer therapies.

Latest Stories

Sherwood Media, LLC produces fresh and unique perspectives on topical financial news and is a fully owned subsidiary of Robinhood Markets, Inc., and any views expressed here do not necessarily reflect the views of any other Robinhood affiliate, including Robinhood Markets, Inc., Robinhood Financial LLC, Robinhood Securities, LLC, Robinhood Crypto, LLC, or Robinhood Money, LLC.